
Loading, please wait...

Loading, please wait...

The Basophil Activation Test utility is rapidly transforming the landscape of food allergy diagnostics. Traditionally, clinicians relied heavily on skin prick tests and specific IgE levels. However, these methods often yield equivocal results. Consequently, patients frequently require an oral food challenge (OFC). Although OFCs remain the gold standard, they carry significant risks of anaphylaxis. Therefore, researchers have refined the BAT as a functional assay that mimics an allergic reaction in vitro.
Recent literature supports the BAT as a powerful tool to complement patient history and standard tests. Specifically, the evidence is strongest for peanut and sesame allergies. Furthermore, data is expanding for milk, egg, and tree nuts. Notable studies, such as the BAT 2 milk trial, demonstrate that BAT can reduce the need for oral food challenges by nearly 50% in children. Moreover, this test excels at distinguishing between asymptomatic sensitization and true clinical allergy. Consequently, it provides clinicians with greater diagnostic certainty before recommending invasive procedures.
Methodological progress has addressed previous barriers to implementation. For instance, new delayed processing strategies allow laboratories more time to handle samples. Additionally, international initiatives now focus on harmonizing performance across different centres. These streamlined workflows make the test more accessible for routine clinical use. However, some limitations persist. Approximately 10% of the population are nonresponders, meaning their basophils do not activate in the assay. Furthermore, universal diagnostic thresholds for all foods are still under development.
Integrating BAT into diagnostic algorithms can optimize patient management. This approach is particularly beneficial in equivocal cases where an OFC would otherwise be mandatory. Clinicians can use BAT results to predict the likelihood of reacting to specific allergens like baked milk or egg. Therefore, this functional biomarker bridges the gap between simple sensitization and real-world reactivity. As protocols become more standardized, the test will likely become a cornerstone of personalized allergy care.
The BAT offers higher specificity compared to skin prick tests or specific IgE. This accuracy helps reduce the number of risky and time-consuming oral food challenges.
Currently, the evidence is most robust for peanut, sesame, and cow\'s milk allergies. Research is also promising for egg and various tree nuts.
No, about 10% of patients are \"nonresponders,\" meaning their cells do not react in the test. In these cases, clinicians must rely on traditional diagnostic methods.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.
References
1. Niegowska M et al. Basophil activation test in food allergy: where are we now? Curr Opin Allergy Clin Immunol. 2026 Apr 07. doi: 10.1097/ACI.0000000000001151. PMID: 41947011.
2. Bergmann MM, Santos AF. Basophil activation test in the food allergy clinic: its current use and future applications. Expert Rev Clin Immunol. 2024 Nov;20(11):1297-1304. doi: 10.1080/1744666X.2024.2336568.
3. Santos AF et al. The Basophil Activation Test Is the Most Accurate Test in Predicting Allergic Reactions to Baked and Fresh Cow\'s Milk During Oral Food Challenges. Allergy. 2025 Oct;80(10):2861-2873. doi: 10.1111/all.16675.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The Basophil Activation Test (BAT) offers superior diagnostic accuracy in food allergy, potentially halving the need for risky oral food challenges....
6 months ago

A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today

A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today

This article reviews the forensic and clinical complexities of acute myocarditis arising on left ventricular hypertrophy in children, highlighting early diagnostic red flags and multidisciplinary postmortem autopsy protocols.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday